menu
    • menu

    Company profile for Rapafusyn Pharmaceuticals

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rapafusyn Pharmaceuticals, based in Baltimore, Maryland, is an up-and-coming pharmaceutical development firm. Leveraging licensed technology from Johns Hopkins University School of Medicine, Rapafusyn focuses on a unique class of natural product-like macrocycles. The company is dedicated to developing novel pharmaceuticals aimed at addressing diseases and fulfilling unmet medical needs in patient care. By harnessing innovative...
    Rapafusyn Pharmaceuticals, based in Baltimore, Maryland, is an up-and-coming pharmaceutical development firm. Leveraging licensed technology from Johns Hopkins University School of Medicine, Rapafusyn focuses on a unique class of natural product-like macrocycles. The company is dedicated to developing novel pharmaceuticals aimed at addressing diseases and fulfilling unmet medical needs in patient care. By harnessing innovative research and strategic partnerships, Rapafusyn Pharmaceuticals aims to advance therapeutic options and make significant contributions to the field of medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rapafusyn PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    855 N. Wolfe Street Baltimore, MD 21205
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rapafusyn.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rapafusyn-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Jun O. Liu, Rapafusyn Founder, Elected NAI Fellow
    Dr. Jun O. Liu, Rapafusyn Founder, Elected NAI Fellow

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rapafusyn-founder-dr-jun-o-liu-elected-as-national-academy-of-inventors-fellow-302639377.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    Rapafusyn Pharma Secures $44M Series A Funding for Molecular
    Rapafusyn Pharma Secures $44M Series A Funding for Molecular

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144896/0/en/Rapafusyn-Pharmaceuticals-Closes-Over-Subscribed-44-Million-Series-A-Financing-to-Advance-Its-Non-Degrading-Molecular-Glue-Drug-Discovery-Platform.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Rapafusyn Pharma Showcases Molecular Glue Platform At WuXi Forum
    Rapafusyn Pharma Showcases Molecular Glue Platform At WuXi Forum

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006455/0/en/Rapafusyn-Pharmaceuticals-to-Showcase-Its-Molecular-Glue-Drug-Discovery-Platform-at-WuXi-Global-Forum.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share
    Rapafusyn to Present at Targeted Protein Degradation Summit
    Rapafusyn to Present at Targeted Protein Degradation Summit

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967995/0/en/Rapafusyn-Announces-an-Upcoming-Oral-Presentation-at-Targeted-Protein-Degradation-Induced-Proximity-Summit.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    Rapafusyn To Present In Vivo Data On ENT1 Inhibitor At ASN 2024
    Rapafusyn To Present In Vivo Data On ENT1 Inhibitor At ASN 2024

    17 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/17/2965018/0/en/Rapafusyn-Pharmaceuticals-to-Present-In-Vivo-Data-on-ENT1-Inhibitor-for-Acute-Kidney-Injury-at-the-American-Society-for-Nephrology-ASN-Kidney-Week-2024.html

    GLOBENEWSWIRE
    17 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search